130 related articles for article (PubMed ID: 28436114)
1. All-Trans-Retinoic Acid Stimulates Overexpression of Tumor Protein D52 (TPD52, Isoform 3) and Neuronal Differentiation of IMR-32 Cells.
Kotapalli SS; Dasari C; Duscharla D; Kami Reddy KR; Kasula M; Ummanni R
J Cell Biochem; 2017 Dec; 118(12):4358-4369. PubMed ID: 28436114
[TBL] [Abstract][Full Text] [Related]
2. Tumor protein D52 (isoform 3) contributes to prostate cancer cell growth via targeting nuclear factor-κB transactivation in LNCaP cells.
Dasari C; Yaghnam DP; Walther R; Ummanni R
Tumour Biol; 2017 May; 39(5):1010428317698382. PubMed ID: 28466782
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.
Ummanni R; Teller S; Junker H; Zimmermann U; Venz S; Scharf C; Giebel J; Walther R
FEBS J; 2008 Nov; 275(22):5703-13. PubMed ID: 18959755
[TBL] [Abstract][Full Text] [Related]
4. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
5. Dyngo-4a Induces Neuroblastoma Cell Differentiation Through The AKT and ERK1/2 Pathway.
Huang J; Zhou Y; Zeng S; Xu J; Liu L; Grothusen J; Liu R
CNS Neurol Disord Drug Targets; 2023; 22(10):1526-1534. PubMed ID: 36476431
[TBL] [Abstract][Full Text] [Related]
6. Tumor protein D52 (isoform 3) induces NF-κB - STAT3 mediated EMT driving neuroendocrine differentiation of prostate cancer cells.
Sruthi KK; Natani S; Ummanni R
Int J Biochem Cell Biol; 2024 Jan; 166():106493. PubMed ID: 37935328
[TBL] [Abstract][Full Text] [Related]
7. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.
Lee JH; Kim KT
J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells.
Joshi S; Guleria R; Pan J; DiPette D; Singh US
Oncogene; 2006 Jan; 25(2):240-7. PubMed ID: 16158052
[TBL] [Abstract][Full Text] [Related]
9. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
[TBL] [Abstract][Full Text] [Related]
11. Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.
Sheikh A; Takatori A; Hossain MS; Hasan MK; Tagawa M; Nagase H; Nakagawara A
Cancer Sci; 2016 Sep; 107(9):1223-32. PubMed ID: 27357360
[TBL] [Abstract][Full Text] [Related]
12. Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma.
Shih YY; Lee H; Nakagawara A; Juan HF; Jeng YM; Tsay YG; Lin DT; Hsieh FJ; Pan CY; Hsu WM; Liao YF
PLoS One; 2011; 6(10):e26236. PubMed ID: 22022577
[TBL] [Abstract][Full Text] [Related]
13. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid enhances killing of neuroblastoma cells by Newcastle disease virus.
Reichard KW; Lorence RM; Katubig BB; Peeples ME; Reyes HM
J Pediatr Surg; 1993 Oct; 28(10):1221-5; discussion 1225-6. PubMed ID: 8263678
[TBL] [Abstract][Full Text] [Related]
15. NRF2 Mediates Neuroblastoma Proliferation and Resistance to Retinoic Acid Cytotoxicity in a Model of In Vitro Neuronal Differentiation.
de Miranda Ramos V; Zanotto-Filho A; de Bittencourt Pasquali MA; Klafke K; Gasparotto J; Dunkley P; Gelain DP; Moreira JCF
Mol Neurobiol; 2016 Nov; 53(9):6124-6135. PubMed ID: 26541884
[TBL] [Abstract][Full Text] [Related]
16. Modulation of HERG current and herg gene expression during retinoic acid treatment of human neuroblastoma cells: potentiating effects of BDNF.
Arcangeli A; Rosati B; Crociani O; Cherubini A; Fontana L; Passani B; Wanke E; Olivotto M
J Neurobiol; 1999 Aug; 40(2):214-25. PubMed ID: 10413451
[TBL] [Abstract][Full Text] [Related]
17. Differentiation, proliferation and adhesion of human neuroblastoma cells after treatment with retinoic acid.
Voigt A; Hartmann P; Zintl F
Cell Adhes Commun; 2000 May; 7(5):423-40. PubMed ID: 10830620
[TBL] [Abstract][Full Text] [Related]
18. Regulation of URG4/URGCP and PPARα gene expressions after retinoic acid treatment in neuroblastoma cells.
Avci CB; Dodurga Y; Gundogdu G; Caglar HO; Kucukatay V; Gunduz C; Satiroglu-Tufan NL
Tumour Biol; 2013 Dec; 34(6):3853-7. PubMed ID: 23821302
[TBL] [Abstract][Full Text] [Related]
19. The expression of multiple proto-oncogenes is differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines.
Thiele CJ; Deutsch LA; Israel MA
Oncogene; 1988 Sep; 3(3):281-8. PubMed ID: 3060792
[TBL] [Abstract][Full Text] [Related]
20. Opposite effects of tumor protein D (TPD) 52 and TPD54 on oral squamous cell carcinoma cells.
Kato K; Mukudai Y; Motohashi H; Ito C; Kamoshida S; Shimane T; Kondo S; Shirota T
Int J Oncol; 2017 May; 50(5):1634-1646. PubMed ID: 28339026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
